vs

Side-by-side financial comparison of INSTEEL INDUSTRIES INC (IIIN) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.

INSTEEL INDUSTRIES INC is the larger business by last-quarter revenue ($159.9M vs $123.8M, roughly 1.3× NATURES SUNSHINE PRODUCTS INC). INSTEEL INDUSTRIES INC runs the higher net margin — 4.7% vs 3.3%, a 1.4% gap on every dollar of revenue. On growth, INSTEEL INDUSTRIES INC posted the faster year-over-year revenue change (23.3% vs 4.7%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $-2.2M). Over the past eight quarters, INSTEEL INDUSTRIES INC's revenue compounded faster (12.0% CAGR vs 5.6%).

Insteel Industries Inc is a leading U.S. manufacturer of steel reinforcing products including welded wire reinforcement and steel fibers. It primarily serves non-residential construction, infrastructure, and precast concrete segments across North America, delivering high-performance reinforcement solutions for various construction projects.

Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.

IIIN vs NATR — Head-to-Head

Bigger by revenue
IIIN
IIIN
1.3× larger
IIIN
$159.9M
$123.8M
NATR
Growing faster (revenue YoY)
IIIN
IIIN
+18.5% gap
IIIN
23.3%
4.7%
NATR
Higher net margin
IIIN
IIIN
1.4% more per $
IIIN
4.7%
3.3%
NATR
More free cash flow
NATR
NATR
$9.8M more FCF
NATR
$7.6M
$-2.2M
IIIN
Faster 2-yr revenue CAGR
IIIN
IIIN
Annualised
IIIN
12.0%
5.6%
NATR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
IIIN
IIIN
NATR
NATR
Revenue
$159.9M
$123.8M
Net Profit
$7.6M
$4.1M
Gross Margin
11.3%
72.5%
Operating Margin
6.0%
4.3%
Net Margin
4.7%
3.3%
Revenue YoY
23.3%
4.7%
Net Profit YoY
602.4%
1379.4%
EPS (diluted)
$0.39
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IIIN
IIIN
NATR
NATR
Q4 25
$159.9M
$123.8M
Q3 25
$177.4M
$128.3M
Q2 25
$179.9M
$114.8M
Q1 25
$160.7M
$113.2M
Q4 24
$129.7M
$118.2M
Q3 24
$134.3M
$114.6M
Q2 24
$145.8M
$110.6M
Q1 24
$127.4M
$111.0M
Net Profit
IIIN
IIIN
NATR
NATR
Q4 25
$7.6M
$4.1M
Q3 25
$14.6M
$5.3M
Q2 25
$15.2M
$5.3M
Q1 25
$10.2M
$4.7M
Q4 24
$1.1M
$-321.0K
Q3 24
$4.7M
$4.3M
Q2 24
$6.6M
$1.3M
Q1 24
$6.9M
$2.3M
Gross Margin
IIIN
IIIN
NATR
NATR
Q4 25
11.3%
72.5%
Q3 25
16.1%
73.3%
Q2 25
17.1%
71.7%
Q1 25
15.3%
72.1%
Q4 24
7.3%
72.0%
Q3 24
9.1%
71.3%
Q2 24
10.6%
71.4%
Q1 24
12.3%
71.2%
Operating Margin
IIIN
IIIN
NATR
NATR
Q4 25
6.0%
4.3%
Q3 25
10.8%
7.0%
Q2 25
11.0%
3.7%
Q1 25
8.3%
5.4%
Q4 24
1.1%
3.8%
Q3 24
4.5%
4.6%
Q2 24
6.0%
5.1%
Q1 24
7.0%
4.2%
Net Margin
IIIN
IIIN
NATR
NATR
Q4 25
4.7%
3.3%
Q3 25
8.2%
4.2%
Q2 25
8.4%
4.6%
Q1 25
6.4%
4.2%
Q4 24
0.8%
-0.3%
Q3 24
3.5%
3.8%
Q2 24
4.5%
1.2%
Q1 24
5.4%
2.1%
EPS (diluted)
IIIN
IIIN
NATR
NATR
Q4 25
$0.39
$0.23
Q3 25
$0.74
$0.30
Q2 25
$0.78
$0.28
Q1 25
$0.52
$0.25
Q4 24
$0.06
$-0.02
Q3 24
$0.24
$0.23
Q2 24
$0.34
$0.07
Q1 24
$0.35
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IIIN
IIIN
NATR
NATR
Cash + ST InvestmentsLiquidity on hand
$15.6M
$93.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$358.8M
$161.6M
Total Assets
$456.1M
$261.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IIIN
IIIN
NATR
NATR
Q4 25
$15.6M
$93.9M
Q3 25
$38.6M
$95.6M
Q2 25
$53.7M
$81.3M
Q1 25
$28.4M
$86.5M
Q4 24
$36.0M
$84.7M
Q3 24
$111.5M
$78.7M
Q2 24
$97.7M
$68.7M
Q1 24
$83.9M
$77.8M
Total Debt
IIIN
IIIN
NATR
NATR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$2.1M
Stockholders' Equity
IIIN
IIIN
NATR
NATR
Q4 25
$358.8M
$161.6M
Q3 25
$371.5M
$166.7M
Q2 25
$356.2M
$163.7M
Q1 25
$341.4M
$167.1M
Q4 24
$331.6M
$161.0M
Q3 24
$350.9M
$162.6M
Q2 24
$346.0M
$156.4M
Q1 24
$340.6M
$159.7M
Total Assets
IIIN
IIIN
NATR
NATR
Q4 25
$456.1M
$261.1M
Q3 25
$462.6M
$264.8M
Q2 25
$471.9M
$254.9M
Q1 25
$421.9M
$252.7M
Q4 24
$404.7M
$240.9M
Q3 24
$422.6M
$245.3M
Q2 24
$414.6M
$235.8M
Q1 24
$397.2M
$247.3M
Debt / Equity
IIIN
IIIN
NATR
NATR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.01×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IIIN
IIIN
NATR
NATR
Operating Cash FlowLast quarter
$-701.0K
$9.9M
Free Cash FlowOCF − Capex
$-2.2M
$7.6M
FCF MarginFCF / Revenue
-1.4%
6.1%
Capex IntensityCapex / Revenue
0.9%
1.9%
Cash ConversionOCF / Net Profit
-0.09×
2.41×
TTM Free Cash FlowTrailing 4 quarters
$439.0K
$28.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IIIN
IIIN
NATR
NATR
Q4 25
$-701.0K
$9.9M
Q3 25
$-17.0M
$18.5M
Q2 25
$28.5M
$4.3M
Q1 25
$-3.3M
$2.6M
Q4 24
$19.0M
$12.2M
Q3 24
$16.2M
$9.6M
Q2 24
$18.8M
$1.3M
Q1 24
$1.4M
$2.2M
Free Cash Flow
IIIN
IIIN
NATR
NATR
Q4 25
$-2.2M
$7.6M
Q3 25
$-18.7M
$16.8M
Q2 25
$26.9M
$3.0M
Q1 25
$-5.5M
$1.5M
Q4 24
$16.3M
$10.0M
Q3 24
$14.5M
$7.9M
Q2 24
$15.5M
$-2.0M
Q1 24
$-580.0K
$-1.5M
FCF Margin
IIIN
IIIN
NATR
NATR
Q4 25
-1.4%
6.1%
Q3 25
-10.6%
13.1%
Q2 25
15.0%
2.6%
Q1 25
-3.5%
1.3%
Q4 24
12.6%
8.5%
Q3 24
10.8%
6.9%
Q2 24
10.7%
-1.9%
Q1 24
-0.5%
-1.4%
Capex Intensity
IIIN
IIIN
NATR
NATR
Q4 25
0.9%
1.9%
Q3 25
1.0%
1.3%
Q2 25
0.9%
1.2%
Q1 25
1.4%
1.0%
Q4 24
2.1%
1.9%
Q3 24
1.3%
1.5%
Q2 24
2.2%
3.0%
Q1 24
1.5%
3.3%
Cash Conversion
IIIN
IIIN
NATR
NATR
Q4 25
-0.09×
2.41×
Q3 25
-1.17×
3.46×
Q2 25
1.88×
0.81×
Q1 25
-0.32×
0.55×
Q4 24
17.56×
Q3 24
3.48×
2.21×
Q2 24
2.86×
0.97×
Q1 24
0.20×
0.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IIIN
IIIN

Welded Wire Reinforcement$108.4M68%
PC Strand$51.6M32%

NATR
NATR

Other$68.1M55%
General Health Products$20.2M16%
Digestive Products$13.8M11%
Cardiovascular Products$12.1M10%
Personal Care Products$4.4M4%
Immunity Products$3.1M3%
Weight Management Products$2.1M2%

Related Comparisons